Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2498 (LINC02498) is a long intergenic non-coding RNA (lincRNA) gene in humans. The lincRNA family consists of non-coding RNAs longer than 200 nucleotides that are transcribed from intergenic regions, do not overlap protein-coding loci, and serve primarily in the regulation of gene expression. LincRNAs such as LINC02498 can impact chromatin structure, transcriptional activity, and RNA stability, typically exerting tissue-specific regulatory effects. Some lincRNAs have enhancer-like functions or are involved in disease processes; however, the specific biological roles, disease associations, and clinical relevance of LINC02498 itself remain largely uncharacterized in the literature to date.
Not applicable – as LINC02498 is not a therapeutic target, drug mechanisms of action do not apply.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2498 (LINC02498).